Methamphetamine and Troriluzole — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Methamphetamine and Troriluzole — Stella

Recruiting

Back to Methamphetamine Use Disorder trials

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(1 site)

United States

Psychopharmacology of Addiction Laboratory, Lexington, Kentucky

Key details

Phase

Very early testing

Sponsor

William Stoops

Collaborators

National Institute on Drug Abuse (NIDA)

Enrollment target

~40 participants

Started

August 2025

Primary completion

February 2029

Age range

18 Years – 55 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov